SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“My perception was that Israel trailed Silicon Valley by 6 months. What I'm feeling is the opposite.”

Trump’s new health policy shake-up threatens global scientific collaboration

Full list of Israeli high-tech funding rounds in 2025

Flō Optics raises $35 million Series A to replace traditional lens coatings with printed tech

Buzz

Most popular

Daily

Weekly

1

Intel slashes employee bonuses amid financial struggles

2

Intel pulls the plug on AI chip designed to rival Nvidia

3

Deel secures $300M secondary transaction at over $12B valuation, hits $800M revenue run rate

4

Unicorn AppsFlyer lays off 100 employees in strategic restructuring

5

Bigabid raises $25 million Series A to boost gaming adtech growth

Patent

2 stories about Patent

חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer

A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug

Your First Investor Meeting, a Survival Guide

27.09.17|Zachi Zach

Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework

Previous Articles